Company Revelation Biosciences, Inc. Nasdaq
Equities
REVBU
US76135L2007
Biotechnology & Medical Research
Business Summary
Number of employees: 9
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Rolke
CEO | Chief Executive Officer | 55 | 01/20/01 |
Chester Zygmont
DFI | Director of Finance/CFO | 44 | 01/20/01 |
Sandra Vedrick
IRC | Investor Relations Contact | - | - |
Robin Marsden
PRN | Corporate Officer/Principal | - | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
George Tidmarsh
CHM | Chairman | 64 | 01/20/01 |
Jess Roper
BRD | Director/Board Member | 59 | 01/20/01 |
James Rolke
CEO | Chief Executive Officer | 55 | 01/20/01 |
Lakhmir Chawla
BRD | Director/Board Member | 53 | 27/23/27 |
Jennifer Carver
BRD | Director/Board Member | 70 | 01/20/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,632,935 | 1,627,645 ( 99.68 %) | 0 | 99.68 % |
Company contact information
Revelation Biosciences, Inc.
4660 LaJolla Village Drive Suite 100
92122, San Diego
+650 800 3717
http://www.revbiosciences.com![address Revelation Biosciences, Inc.(REVBU)](https://cdn.zonebourse.com/static/address/131686324.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+22.10% | 4.65TCr | |
+46.45% | 4.18TCr | |
-3.12% | 4.08TCr | |
+36.10% | 3.3TCr | |
-6.30% | 2.83TCr | |
+18.71% | 2.78TCr | |
+46.15% | 1.43TCr | |
+44.52% | 1.37TCr | |
+0.19% | 1.22TCr |